The objective was to determine if there is an increased risk to develop exacerbations in patients with multiple sclerosis (MS) after assisted reproduction technique (ART). An increase in annual relapse rate (ARR) was described after ART in a small cohort of patients. We investigated the associations between ART and relapse rate (RR) in 23 MS patients who underwent 78 hormonal stimulations in total. There was a statistically significant increase in the RR following ART independent of the hormonal approach or the time interval between the stimulations. These results suggest that female MS patients who wish to have children should be informed that the RR may be increasing if ART is necessary.

Keywords:
Multiple sclerosis, Infertility, Assisted reproduction technique, Relapse rate
1.
Ferrero S, Pretta S, Ragni N: Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004;115:3–9.
2.
Laplaud DA, Leray E, Barriere P, Wiertlewski S, Moreau T: Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 2006;66:1280–1281.
3.
Hellwig K, Beste C, Brune N, Haghikia A, Müller T, Schimrigk S, Gold R: Increased MS relapse rate during assisted reproduction technique. J Neurol 2008;255:592–593.
4.
Dwosh E, Guimond C, Duquette P, Sadovnick AD: The interaction of MS and pregnancy: a critical review. Int MS J 2003;10:38–42.
5.
Voskuhl RR: Hormone-based therapies in MS. Int MS J 2003;10:60–66.
6.
Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P Confavreux C, The Pregnancy In Multiple Sclerosis Group: Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004;127:1353–1360.
7.
Devonshire V, Duquette P, Dwosh E, Guimond C, Sadovnick AD: The immune system and hormones: review and relevance to pregnancy and contraception in women with MS. Int MS J 2003;10:45–50.
8.
Buljevac D, Hop WC, Reedeker W, Janssens AC, van der Meche FG, van Doorn PA, Hintzen RQ: Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ 2003;327:646.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.